Other

OCI Unrealized Holding Gain (Loss) on Securities, Net of Tax

Revolution Medicines, Inc. OCI Unrealized Holding Gain (Loss) on Securities, Net of Tax decreased by 3282.6% to -$3.85M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1097.7%, from $386.00K to -$3.85M. Over 3 years (FY 2021 to FY 2025), OCI Unrealized Holding Gain (Loss) on Securities, Net of Tax shows an upward trend with a 57.3% CAGR.

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2021
Last reportedQ1 2026May 6, 2026
Metric ID: cop_oci_unrealized_holding_gain_loss_on_securities_net_of_tax

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value-$123.00K-$123.00K-$123.00K$581.00K$581.00K$581.00K$581.00K$1.22M-$695.00K$380.00K$1.42M-$1.74M-$665.00K$5.68M$386.00K-$405.00K$1.81M$121.00K-$3.85M
QoQ Change—+0.0%+0.0%+572.4%+0.0%+0.0%+0.0%+110.7%-156.8%+154.7%+272.4%-223.1%+61.8%+953.4%-93.2%-204.9%+547.9%-93.3%<-999%
YoY Change————+572.4%+572.4%+572.4%+110.7%-219.6%-34.6%+143.5%-242.3%+4.3%>999%+122.2%+39.1%-68.0%—<-999%
Range-$3.85M – $5.68M
CAGR+115.0%
Avg YoY Growth+133.4%
Median YoY Growth+74.9%
Current Streak2 quarters decline

Frequently Asked Questions

What is Revolution Medicines, Inc.'s oci unrealized holding gain (loss) on securities, net of tax?
Revolution Medicines, Inc. (RVMD) reported oci unrealized holding gain (loss) on securities, net of tax of -$3.85M in Q1 2026.
How has Revolution Medicines, Inc.'s oci unrealized holding gain (loss) on securities, net of tax changed year-over-year?
Revolution Medicines, Inc.'s oci unrealized holding gain (loss) on securities, net of tax decreased by 1097.7% year-over-year, from $386.00K to -$3.85M.
What is the long-term trend for Revolution Medicines, Inc.'s oci unrealized holding gain (loss) on securities, net of tax?
Over 3 years (2021 to 2025), Revolution Medicines, Inc.'s oci unrealized holding gain (loss) on securities, net of tax has grown at a 57.3% compound annual growth rate (CAGR), from -$492.00K to $1.92M.